India Malaria Diagnostics Market Size to Reach US$ 81.6 Mn by 2032, Forecasted CAGR of 4.1% - Persistence Market Research

The India malaria diagnostics market is witnessing steady growth on the back of government-led initiatives, strategic collaborations, and technological innovations. According to Persistence Market Research, the market size is projected to reach US$ 81.6 Mn in 2032 from US$ 61.6 Mn in 2025, expanding at a CAGR of 4.1% during the forecast period. Increasing adoption of advanced molecular diagnostics and rapid diagnostic tests (RDTs) has made early and accurate detection possible even in low-resource settings.

Rapid Diagnostic Tests are expected to dominate the market, holding around 54.2% share in 2025, due to their speed and accessibility. East India is anticipated to lead the market geographically, primarily because of high malaria prevalence in states such as Odisha, Jharkhand, and Assam. The region's climatic conditions, combined with persistent tribal and forest-based transmission zones, continue to drive demand for diagnostic solutions.

Get a Sample Copy of Research Report (Use Corporate Mail id for Quick Response): https://www.persistencemarketresearch.com/samples/35426

Key Highlights from the Report

• India malaria diagnostics market size expected to hit US$ 81.6 Mn by 2032.
• Rapid Diagnostic Tests (RDTs) projected to account for 54.2% share in 2025.
• Molecular diagnostics gaining adoption to detect low-parasitemia and asymptomatic infections.
• East India remains the leading region due to high malaria incidence in Odisha and neighboring states.
• Hospitals and clinics estimated to capture nearly 45.6% share in 2025.
• CAGR of 4.1% forecast between 2025 and 2032.

Market Segmentation

The India malaria diagnostics market can be segmented by technology into microscopy, Rapid Diagnostic Tests (RDTs), and molecular diagnostics. While microscopy has been the gold standard, its limitations in detecting low-density infections are pushing the adoption of advanced tools. RDTs are expected to hold the lion's share due to their portability and quick results, particularly useful in remote and rural healthcare settings. Molecular diagnostics such as PCR are growing in adoption, particularly for asymptomatic carriers and low-endemic zones.

By end-use, the market is segmented into hospitals & clinics, diagnostic centers, and academic/research institutions. Hospitals and clinics are forecast to dominate, capturing nearly 45.6% share in 2025, due to their central role in treating severe malaria cases and reporting confirmed cases to public health authorities. Diagnostic centers are also expanding rapidly, leveraging advanced laboratory infrastructure and specialized testing capabilities to improve detection rates.

Read Detailed Analysis: https://www.persistencemarketresearch.com/market-research/india-malaria-diagnostics-market.asp

Regional Insights

In East India, states such as Odisha, Assam, and Jharkhand report the highest malaria incidence. Odisha alone contributed nearly 18.7% of India's total malaria burden in 2023. Programs such as DAMaN have been crucial in expanding rapid diagnostic coverage in these regions.

In North India, Punjab and Haryana have made strides in reducing malaria prevalence. However, studies reveal that conventional microscopy misses a significant proportion of submicroscopic infections, highlighting the need for PCR-based tools. Surveillance challenges due to fragmented reporting remain a concern in the region.

In West India, including Maharashtra, Gujarat, and Rajasthan, outreach programs and free blood smear testing have been the mainstay. However, delays in microscopy often lead to presumptive treatment. RDTs are increasingly being integrated into diagnostic protocols to ensure timely and accurate treatment.

Market Drivers

Government-led interventions, along with support from global organizations, are key growth drivers. Programs such as the National Strategic Plan for Malaria Elimination, coupled with technical and financial aid from WHO and the Global Fund, are improving diagnostic accessibility. Additionally, innovations such as AI-enabled microscopes and portable testing kits are bridging diagnostic gaps in rural and tribal regions.

Market Restraints

One of the major restraints is the diagnostic gap in microscopy, which continues to be widely used despite its limitations. Studies show that microscopy can miss up to 25% of malaria cases, especially in low-endemic zones. Submicroscopic infections and mixed-species cases often remain undetected, undermining elimination efforts and delaying treatment.

Market Opportunities

The emergence of genomic surveillance through Next-Generation Sequencing (NGS) offers significant opportunities. NGS helps track regional drug resistance patterns, enabling the development of tailored antimalarial strategies. Collaborative initiatives, such as the India International Centers of Excellence for Malaria Research (ICEMR), are leveraging NGS to study parasite genetic diversity, strengthening the country's elimination strategy and opening new avenues for diagnostic advancements.

Request for Customization of the Research Report: https://www.persistencemarketresearch.com/request-customization/35426

Reasons to Buy the Report

• Provides in-depth market size and growth forecast till 2032.
• Identifies leading technology segments and their adoption trends.
• Offers detailed regional insights with state-level malaria prevalence data.
• Examines government policies, global partnerships, and funding impacts.
• Profiles key players with competitive landscape and latest developments.

Frequently Asked Questions (FAQs)

• How Big is the India Malaria Diagnostics Market?
• Who are the Key Players in the Global Market for Malaria Diagnostics?
• What is the Projected Growth Rate of the Market between 2025 and 2032?
• What is the Market Forecast for Malaria Diagnostics in 2032?
• Which Region is Estimated to Dominate the Industry through the Forecast Period?

Company Insights

• Bio-Rad Laboratories Inc.
• Access Bio Inc.
• Abbott India Limited
• Hologic, Inc.
• Roche Diagnostics India Pvt. Ltd.
• Sysmex India Private Limited
• Becton Dickinson India Private Limited
• Siemens Healthineers AG
• Meridian Bioscience, Inc.
• Olympus Corporation
• Nikon India Pvt Ltd
• Beckman Coulter, Inc.
• MicroGene Diagnostic Systems (P) Ltd
• Premier Medical
• BIOMÉRIEUX

Recent Developments

• In April 2025, Mizoram's NVBDCP announced intensified efforts through Source Reduction Drive (SRD) to combat malaria prevalence and move toward malaria-free villages.
• In May 2024, Serum Institute of India shipped its first batch of R21/Matrix-M malaria vaccines to Africa, marking a milestone in global malaria prevention.

Conclusion

The India malaria diagnostics market is at a pivotal stage, shaped by government programs, private-public partnerships, and technological advancements. While challenges remain in terms of diagnostic gaps and rural accessibility, the increasing adoption of RDTs, molecular diagnostics, and genomic surveillance promises significant improvements in detection and elimination strategies. With East India continuing as the epicenter of demand and hospitals driving adoption, the market is poised for consistent growth, ultimately supporting India's vision of becoming malaria-free in the coming decades.

Read More Related Reports:

Mirna Sequencing And Assay Market https://www.persistencemarketresearch.com/market-research/mirna-sequencing-and-assay-market.asp Healthcare
Intravenous Solutions Market https://www.persistencemarketresearch.com/market-research/intravenous-solutions-market.asp Healthcare
Gmp Testing Service Market https://www.persistencemarketresearch.com/market-research/gmp-testing-service-market.asp Healthcare
Per Diem Nurse Staffing Market https://www.persistencemarketresearch.com/market-research/per-diem-nurse-staffing-market.asp Healthcare
Treatment Planning Systems And Advanced Image Processing Market https://www.persistencemarketresearch.com/market-research/treatment-planning-systems-and-advanced-image-processing-market.asp Healthcare

Contact Us:

Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com

About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

This release was published on openPR.